Angiotensin receptor blockers following acute stroke

References

• Bath P, Chalmers J, Powers W et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J. Hypertens.21, 665–672 (2003).
   PubMed Web of Science ®Google Scholar
• Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology65, 1179–1183 (2005).
   PubMed Web of Science ®Google Scholar
• Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke33, 1315–1320 (2002).
   PubMed Web of Science ®Google Scholar
• Castillo J, Leira R, Garcia MM et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke35, 520–526 (2004).
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke38, 1655–1711 (2007).
   PubMed Web of Science ®Google Scholar
• Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke17, 861–864 (1986).
   PubMed Web of Science ®Google Scholar
• Oliveira-Filho J, Silva SC, Trabuco CC et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology61, 1047–1051 (2003).
   PubMed Web of Science ®Google Scholar
• Mattle HP, Kappeler L, Arnold M et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke36, 264–268 (2005).
   PubMed Web of Science ®Google Scholar
• Ohwaki K, Yano E, Nagashima H et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke35, 1364–1367 (2004).
   PubMed Web of Science ®Google Scholar
• Powers WJ. Intracerebral hemorrhage and head trauma: common effects and common mechanisms of injury. Stroke41, S107–S110 (2010).
   Web of Science ®Google Scholar
• Anderson CS, Huang Y, Wang JG et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol.7, 391–399 (2008).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Palesch YY, Martin R et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch. Neurol.67, 570–576 (2010).
   PubMed Web of Science ®Google Scholar
• Arima H, Anderson CS, Wang JG et al. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension56, 852–858 (2010).
   PubMed Web of Science ®Google Scholar
• Saad MA, Abbas AM, Boshra V, Elkhateeb M, El Aal IA. Effect of angiotensin II type 1 receptor blocker, candesartan, and β 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol. Hung.97, 159–171 (2010).
   PubMedGoogle Scholar
• Jilma B, Li-Saw-Hee FL, Wagner OF, Beevers DG , Lip GY. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. Clin. Sci. (Lond.)103, 131–136 (2002).
   PubMed Web of Science ®Google Scholar
• Li J, Culman J, Hortnagl H et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J.19, 617–619 (2005).
   PubMed Web of Science ®Google Scholar
• Iwai M, Liu HW, Chen R et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation110, 843–848 (2004).
   PubMed Web of Science ®Google Scholar
• Krikov M, Thone-Reineke C, Muller S, Villringer A, Unger T. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens.26, 544–552 (2008).
   PubMed Web of Science ®Google Scholar
• Kozak W, Kozak A, Johnson MH, Elewa HF, Fagan SC. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J. Pharmacol. Exp. Ther.326, 773–782 (2008).
   PubMed Web of Science ®Google Scholar
• Kozak A, Ergul A, El-Remessy AB et al. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke40, 1870–1876 (2009).
   PubMed Web of Science ®Google Scholar
• Fagan SC, Hess DC, Machado LS et al. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy25, 387–395 (2005).
   PubMed Web of Science ®Google Scholar
• Fagan SC, Kozak A, Hill WD et al. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J. Hypertens.24, 535–539 (2006).
   PubMed Web of Science ®Google Scholar
• Schrader J, Luders S, Kulschewski A et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke34, 1699–1703 (2003).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Garcia JL, Botia E, de La Sierra A, Villanueva MA, Gonzalez-Spinola J. Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke. Am. J. Hypertens.18, 379–384 (2005).
   PubMed Web of Science ®Google Scholar
• Potter JF, Robinson TG, Ford GA et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol.8, 48–56 (2009).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S. Renin–angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase. J. Stroke Cerebrovasc. Dis.19, 435–440 (2010).
   PubMed Web of Science ®Google Scholar
• Bath PM, Martin RH, Palesch Y et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke40, 3541–3546 (2009).
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Hemphill JC 3rd, Anderson C et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke41, 2108–2129 (2010).
   PubMed Web of Science ®Google Scholar
• Sandset EC, Bath PM, Boysen G et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet377, 741–750 (2011).
   PubMed Web of Science ®Google Scholar
• Sare, GM, Ali M, Shuaib A, Bath PM. Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration. Stroke40, 2098–2103 (2009).
   PubMed Web of Science ®Google Scholar
• Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke28, 1–5 (1997).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Saver JL, Fredieu A et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke35, 2879–2883 (2004).
   PubMed Web of Science ®Google Scholar
• Geeganage C, Tracy M, England T et al. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke42, 491–493 (2011).
   PubMed Web of Science ®Google Scholar
• Yong M, Diener HC, Kaste M, Mau J. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke36, 2619–2625 (2005).
   PubMed Web of Science ®Google Scholar
• Ko Y, Park JH, Yang MH et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke41, 2512–2518 (2010).
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol.9, 469–480 (2010).
   PubMed Web of Science ®Google Scholar
• Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet375, 906–915 (2010).
   PubMed Web of Science ®Google Scholar
• Leira R, Millan M, Diez-Tejedor E et al. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: the TICA study. Hypertension54, 769–774 (2009).
   PubMed Web of Science ®Google Scholar
• Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br. Med. J.1, 507–510 (1973).
   PubMed Web of Science ®Google Scholar
• Spence JD. Pseudo-hypertension in the elderly: still hazy, after all these years. J. Hum. Hypertens.11, 621–623 (1997).
   PubMed Web of Science ®Google Scholar
• Robinson TG, Potter JF, Ford GA et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol.9, 767–775 (2010).
   PubMed Web of Science ®Google Scholar
• Anderson CS, Huang Y, Arima H et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke41, 307–312 (2010).
   PubMed Web of Science ®Google Scholar